{"nct_id":"NCT02214121","title":"A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2014-09-11","start_date_type":"ACTUAL","primary_completion_date":"2017-02-27","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}